Who is sponsoring NCT03843658?

NCT03843658 is sponsored by Arthritis Northwest PLLC.

What drugs are being tested in NCT03843658?

Interventions in NCT03843658: There is no intervention, but a diagnosis..

What condition does NCT03843658 study?

NCT03843658 studies Rheumatologic Disorder.

Is NCT03843658 still recruiting?

NCT03843658 is currently status unknown. Last updated 18 February 2019.

Last reviewed 2019-02-18 · How we verify

NCT03843658

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Identifying Novel Biomarkers in Early Rheumatology Patients

Status unknown Last updated 18 February 2019

What this trial tests

trial testing There is no intervention, but a diagnosis. in Rheumatologic Disorder in 300 participants. Status unknown.

Timeline

15 March 2019

Primary endpoint
15 March 2020

15 September 2020

Quick facts

Lead sponsor	Arthritis Northwest PLLC
Status	Status unknown
Study type	OBSERVATIONAL
Enrollment	300
Start date	15 March 2019
Primary completion	15 March 2020
Estimated completion	15 September 2020

Drugs / interventions tested

There is no intervention, but a diagnosis.

Conditions studied

Rheumatologic Disorder — all drugs for Rheumatologic Disorder →

Sponsor

Arthritis Northwest PLLC

Who can join

Adults 18 to 100, any sex, with Rheumatologic Disorder. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Patients new to a rheumatology practice will be asked if they want to consent to their blood sample, medical records, and hand/foot x-rays (with sharp scores) for the analysis and correlation with the diagnosis they will receive from the rheumatologist.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other Arthritis Northwest PLLC trials

Trials by the same sponsor.

NCT03843619 — Electronic and Lab Pre-screening of New Rheumatology Patients With Rheumatoid Arthritis · unknown

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT03843658 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Arthritis Northwest PLLC
Last refreshed: 18 February 2019

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03843658.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing